Inspiration Healthcare Group PLC (GB:IHC)
LSE:IHC
Want to see GB:IHC full AI Analyst Report?
Top Page
Inspiration Healthcare
(LSE:IHC)
Select Model
Select Model
Rating:53Neutral
Price Target:
24.00 p
▲(62.71% Upside)
Action:Reiterated
Date:06/18/26
The score is driven primarily by improving 2026 fundamentals—especially the sharp rebound in operating and free cash flow—offset by continued net losses and prior-year volatility. Technical indicators are currently weak (bearish trend with negative MACD) despite oversold readings, and valuation is constrained by a negative P/E with no dividend yield provided.
Positive Factors
Improved cash generation
A material swing to strong operating and free cash flow in 2026 increases the company's ability to self-fund working capital, service and consumable inventory, and maintenance operations. Sustained positive cash generation reduces refinancing needs and supports reinvestment in products and services.
Negative Factors
Still loss-making at net level
Persisting net losses constrain retained earnings and limit capacity to fund strategic initiatives from profits. Even with an operating profit recovery, negative net margins imply ongoing non-operating costs or historic write-downs that could hamper long-term capital accumulation and investor confidence.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved cash generation
A material swing to strong operating and free cash flow in 2026 increases the company's ability to self-fund working capital, service and consumable inventory, and maintenance operations. Sustained positive cash generation reduces refinancing needs and supports reinvestment in products and services.
Read all positive factors
Inspiration Healthcare (IHC) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£20.17M
Dividend YieldN/A
Average Volume (3M)40.35K
Price to Earnings (P/E)―
Beta (1Y)0.30
Revenue Growth24.30%
EPS Growth93.53%
CountryUK
Employees224
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.01
Shares Outstanding89,663,370
10 Day Avg. Volume75,140
30 Day Avg. Volume40,346
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)0.89
Price to Sales (P/S)0.29
P/FCF Ratio2.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)£40.74M
Inspiration Healthcare Business Overview & Revenue Model
Company Description
Inspiration Healthcare Group plc (IHC.L) is a global provider of advanced medical technology, catering to critical care, operating theatre, and home healthcare applications worldwide. The company offers a comprehensive range of products, with a st...
How the Company Makes Money
IHC makes money primarily by selling medical devices and consumables to healthcare providers. Its revenue model typically includes: (1) Product sales: income from supplying third-party medical equipment and consumables (and any owned brands/produc...
Inspiration Healthcare Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
58
Neutral
Cash Flow
66
Positive
| Breakdown | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 47.55M | 38.25M | 37.63M | 41.23M | 41.05M |
| Gross Profit | 20.07M | 16.38M | 17.89M | 17.63M | 20.25M |
| EBITDA | 2.37M | -12.44M | -2.43M | 2.76M | 6.17M |
| Net Income | -1.04M | -14.97M | -6.03M | 272.00K | 4.23M |
Balance Sheet | |||||
| Total Assets | 35.71M | 41.08M | 49.01M | 54.89M | 50.11M |
| Cash, Cash Equivalents and Short-Term Investments | 1.17M | 733.00K | 609.00K | 2.28M | 9.25M |
| Total Debt | 11.77M | 14.97M | 12.83M | 13.08M | 7.54M |
| Total Liabilities | 20.04M | 24.45M | 20.05M | 19.42M | 14.62M |
| Stockholders Equity | 15.67M | 16.64M | 28.97M | 35.47M | 35.49M |
Cash Flow | |||||
| Free Cash Flow | 6.27M | -3.52M | 380.00K | -11.86M | -436.00K |
| Operating Cash Flow | 6.88M | -1.55M | 2.01M | -3.52M | 3.54M |
| Investing Cash Flow | -2.97M | -1.74M | -2.69M | -8.34M | -3.97M |
| Financing Cash Flow | -3.47M | 3.61M | -1.19M | 4.88M | -964.00K |
Inspiration Healthcare Technical Analysis
Negative
14.75
Price Trends
26.93
Negative
23.99
Negative
21.38
Positive
Market Momentum
-1.12
Positive
22.61
Positive
9.31
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IHC, the sentiment is Negative. The current price of 14.75 is below the 20-day moving average (MA) of 26.52, below the 50-day MA of 26.93, and below the 200-day MA of 21.38, indicating a neutral trend. The MACD of -1.12 indicates Positive momentum. The RSI at 22.61 is Positive, neither overbought nor oversold. The STOCH value of 9.31 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:IHC.
Inspiration Healthcare Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £185.99M | 23.53 | 23.64% | 3.48% | 13.71% | 27.65% | |
70 Outperform | £9.60B | 20.32 | 11.79% | 2.35% | 2.84% | 47.82% | |
67 Neutral | £4.02B | 30.35 | 10.53% | 2.11% | 3.29% | -10.58% | |
58 Neutral | £493.40M | 49.64 | 3.87% | 1.25% | 28.96% | 39.58% | |
53 Neutral | £20.17M | -19.35 | -69.35% | ― | 24.30% | 93.53% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | £4.43M | -4.86 | -16.78% | ― | -2.87% | 52.38% |
* Healthcare Sector Average
GB:IHC
Inspiration Healthcare
22.50
-1.70
-7.02%
GB:AMS
Advanced Medical Solutions
228.00
23.19
11.32%
GB:CTEC
ConvaTec
206.00
-70.75
-25.56%
GB:SUN
Surgical Innovations
0.48
-0.22
-32.14%
GB:TSTL
Tristel
387.50
36.36
10.36%
GB:SN
Smith & Nephew
1,132.50
77.95
7.39%
Inspiration Healthcare Corporate Events
Business Operations and StrategyFinancial Disclosures
Inspiration Healthcare boosts profits and cash as it refocuses on core neonatal tech
Positive
Jun 16, 2026
Inspiration Healthcare reported a strong FY26 performance, with revenue rising 24% to £47.5m, driven by a 56% surge in SLE product sales, improved gross margins and a swing to £2.8m in adjusted EBITDA. Tighter working capital management ...
Business Operations and StrategyFinancial Disclosures
Inspiration Healthcare sets date for full-year results and ramps up investor outreach
Positive
Jun 2, 2026
Inspiration Healthcare Group is a UK-based global medical technology company focused on neonatal intensive care, providing ventilators, other capital equipment and single-use disposables that support even the most premature babies. It sells direct...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Inspiration Healthcare to Exit Micrel Infusion Distribution and Refocus on Neonatal Core
Positive
Jun 2, 2026
Inspiration Healthcare Group has agreed to transfer the UK distribution of Micrel Medical Devices’ ambulatory infusion pumps and consumables back to a Micrel-controlled entity, ending its exclusive distributor role on 31 January 2027. The bu...
Business Operations and Strategy
Inspiration Healthcare appoints Singer Capital Markets as nominated adviser and joint broker
Positive
Apr 14, 2026
Inspiration Healthcare Group plc, a UK-based global medical technology company specialising in neonatal intensive care devices and related technologies, supplies its own branded and distributed products to hospitals in the UK, Ireland and over 75 ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.